Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 339 entries
Sorted by: Best Match Show Resources per page
Radix Puerariae lobatae (Gegen) suppresses the anticoagulation effect of warfarin: a pharmacokinetic and pharmacodynamics study.

Chinese medicine

Ge B, Zhang Z, Zuo Z.
PMID: 26925159
Chin Med. 2016 Feb 27;11:7. doi: 10.1186/s13020-016-0078-9. eCollection 2016.

BACKGROUND: Radix Salvia miltiorrhiza (Danshen) and Radix Puerariae lobatae (Gegen) are used in Traditional Chinese Medicine to treat cardiovascular diseases. However, adverse herb-drug interactions were observed between warfarin and herbal remedies containing Danshen and Gegen. This study aims to...

Cite
Ge B, Zhang Z, Zuo Z. Radix Puerariae lobatae (Gegen) suppresses the anticoagulation effect of warfarin: a pharmacokinetic and pharmacodynamics study. Chin Med. 2016;11:7doi: 10.1186/s13020-016-0078-9.
Ge, B., Zhang, Z., & Zuo, Z. (2016). Radix Puerariae lobatae (Gegen) suppresses the anticoagulation effect of warfarin: a pharmacokinetic and pharmacodynamics study. Chinese medicine, 117. https://doi.org/10.1186/s13020-016-0078-9
Ge, Beikang, et al. "Radix Puerariae lobatae (Gegen) suppresses the anticoagulation effect of warfarin: a pharmacokinetic and pharmacodynamics study." Chinese medicine vol. 11 (2016): 7. doi: https://doi.org/10.1186/s13020-016-0078-9
Ge B, Zhang Z, Zuo Z. Radix Puerariae lobatae (Gegen) suppresses the anticoagulation effect of warfarin: a pharmacokinetic and pharmacodynamics study. Chin Med. 2016 Feb 27;11:7. doi: 10.1186/s13020-016-0078-9. eCollection 2016. PMID: 26925159; PMCID: PMC4769563.
Copy Download .nbib Format: NLM
Urinary Bladder Adenocarcinoma Metastatic to the Abdominal Wall: Report of a Case with Cytohistologic Correlation.

Case reports in pathology

Nath V, Baliga M.
PMID: 27006847
Case Rep Pathol. 2016;2016:8608412. doi: 10.1155/2016/8608412. Epub 2016 Feb 23.

We report a case of adenocarcinoma metastatic to the abdominal wall in a 71-year-old man with a history of primary bladder adenocarcinoma. CT-guided core biopsy was performed; imprints and histologic sections showed malignant glands lined by tumor cells with...

Cite
Nath V, Baliga M. Urinary Bladder Adenocarcinoma Metastatic to the Abdominal Wall: Report of a Case with Cytohistologic Correlation. Case Rep Pathol. 2016;2016:8608412doi: 10.1155/2016/8608412.
Nath, V., & Baliga, M. (2016). Urinary Bladder Adenocarcinoma Metastatic to the Abdominal Wall: Report of a Case with Cytohistologic Correlation. Case reports in pathology, 20168608412. https://doi.org/10.1155/2016/8608412
Nath, Vikas, and Baliga, Mithra. "Urinary Bladder Adenocarcinoma Metastatic to the Abdominal Wall: Report of a Case with Cytohistologic Correlation." Case reports in pathology vol. 2016 (2016): 8608412. doi: https://doi.org/10.1155/2016/8608412
Nath V, Baliga M. Urinary Bladder Adenocarcinoma Metastatic to the Abdominal Wall: Report of a Case with Cytohistologic Correlation. Case Rep Pathol. 2016;2016:8608412. doi: 10.1155/2016/8608412. Epub 2016 Feb 23. PMID: 27006847; PMCID: PMC4781945.
Copy Download .nbib Format: NLM
Transthoracic fine-needle aspiration cytology of non-invasive, low-grade urothelial carcinoma with lung metastasis: A case report with review of the literature.

Journal of cytology

Vural Ç, Yildiz K, Çabuk D, Akgül A.
PMID: 26229254
J Cytol. 2015 Apr-Jun;32(2):132-5. doi: 10.4103/0970-9371.160572.

Radiological analyses in a 61-year-old patient being followed since 2005 for low-grade, non-invasive urothelial carcinoma (UC) (Ta) revealed a 5-cm pleural-based mass in the lower lobe of the right lung for which a subsequent transthoracic fine-needle aspiration cytology was...

Cite
Vural Ç, Yildiz K, Çabuk D, et al. Transthoracic fine-needle aspiration cytology of non-invasive, low-grade urothelial carcinoma with lung metastasis: A case report with review of the literature. J Cytol. 2015;32(2):132-5doi: 10.4103/0970-9371.160572.
Vural, �. �., Yildiz, K., Çabuk, D., & Akgül, A. (2015). Transthoracic fine-needle aspiration cytology of non-invasive, low-grade urothelial carcinoma with lung metastasis: A case report with review of the literature. Journal of cytology, 32(2), 132-5. https://doi.org/10.4103/0970-9371.160572
Vural, ÇiĞdem, et al. "Transthoracic fine-needle aspiration cytology of non-invasive, low-grade urothelial carcinoma with lung metastasis: A case report with review of the literature." Journal of cytology vol. 32,2 (2015): 132-5. doi: https://doi.org/10.4103/0970-9371.160572
Vural Ç, Yildiz K, Çabuk D, Akgül A. Transthoracic fine-needle aspiration cytology of non-invasive, low-grade urothelial carcinoma with lung metastasis: A case report with review of the literature. J Cytol. 2015 Apr-Jun;32(2):132-5. doi: 10.4103/0970-9371.160572. PMID: 26229254; PMCID: PMC4520048.
Copy Download .nbib Format: NLM
Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera.

Hematology (Amsterdam, Netherlands)

Musolino C, Alonci A, Bellomo G, Tringali O, Spatari G, Quartarone C, Rizzo V, Calabrò L, Bagnato G, Frisina N.
PMID: 27426843
Hematology. 1999;4(5):397-402. doi: 10.1080/10245332.1999.11746464.

Vascular complications are the main cause of morbidity in polycythemia vera (PV) and essential thrombocythemia (ET). To investigate plasma concentrations of soluble P-selectin (sP-Sel.), soluble E-selectin (sE-Sel.) and soluble thrombomodulin (sTM) in relation to the presence of thromboembolic events...

Cite
Musolino C, Alonci A, Bellomo G, et al. Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. Hematology. 1999;4(5):397-402doi: 10.1080/10245332.1999.11746464.
Musolino, C., Alonci, A., Bellomo, G., Tringali, O., Spatari, G., Quartarone, C., Rizzo, V., Calabrò, L., Bagnato, G., & Frisina, N. (1999). Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. Hematology (Amsterdam, Netherlands), 4(5), 397-402. https://doi.org/10.1080/10245332.1999.11746464
Musolino, C, et al. "Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera." Hematology (Amsterdam, Netherlands) vol. 4,5 (1999): 397-402. doi: https://doi.org/10.1080/10245332.1999.11746464
Musolino C, Alonci A, Bellomo G, Tringali O, Spatari G, Quartarone C, Rizzo V, Calabrò L, Bagnato G, Frisina N. Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. Hematology. 1999;4(5):397-402. doi: 10.1080/10245332.1999.11746464. PMID: 27426843.
Copy Download .nbib Format: NLM
PO-14 - Tumour expression of coagulation proteases of the aPC pathway - a role in the pathogenesis of gynaecological cancers?.

Thrombosis research

Martin F, Long JC, O'Toole SA, O'Leary JJ, Abu Saadeh F, Gleeson N, Norris LA.
PMID: 27161702
Thromb Res. 2016 Apr;140:S181. doi: 10.1016/S0049-3848(16)30147-5. Epub 2016 Apr 08.

INTRODUCTION: The close relationship between coagulation, thrombosis and cancer has long been established. Gynaecological cancers, in particular ovarian cancers, carry a high risk of thrombosis but coagulation activation is also thought to play a role in tumorigenesis and metastasis....

Cite
Martin F, Long JC, O'Toole SA, et al. PO-14 - Tumour expression of coagulation proteases of the aPC pathway - a role in the pathogenesis of gynaecological cancers?. Thromb Res. 2016;140:S181doi: 10.1016/S0049-3848(16)30147-5.
Martin, F., Long, J. C., O'Toole, S. A., O'Leary, J. J., Abu Saadeh, F., Gleeson, N., & Norris, L. A. (2016). PO-14 - Tumour expression of coagulation proteases of the aPC pathway - a role in the pathogenesis of gynaecological cancers?. Thrombosis research, 140S181. https://doi.org/10.1016/S0049-3848(16)30147-5
Martin, F, et al. "PO-14 - Tumour expression of coagulation proteases of the aPC pathway - a role in the pathogenesis of gynaecological cancers?." Thrombosis research vol. 140 (2016): S181. doi: https://doi.org/10.1016/S0049-3848(16)30147-5
Martin F, Long JC, O'Toole SA, O'Leary JJ, Abu Saadeh F, Gleeson N, Norris LA. PO-14 - Tumour expression of coagulation proteases of the aPC pathway - a role in the pathogenesis of gynaecological cancers?. Thromb Res. 2016 Apr;140:S181. doi: 10.1016/S0049-3848(16)30147-5. Epub 2016 Apr 08. PMID: 27161702.
Copy Download .nbib Format: NLM
Lessons learned from a case of abdominal aortic aneurysm accompanied by unstable coagulopathy.

Case reports in vascular medicine

Hoshina K, Kaneko M, Hosaka A, Okamoto H, Shigematsu K, Miyata T.
PMID: 22934232
Case Rep Vasc Med. 2012;2012:265860. doi: 10.1155/2012/265860. Epub 2012 Aug 09.

Preoperative examination for abdominal aortic aneurysms (AAAs) occasionally reveals an abnormal decrease in coagulation factors and thrombocytopenia, fulfilling the criteria for disseminated intravascular coagulation (DIC). Treatment of the underlying disorder is indispensable for alleviating DIC. We report an uncommon...

Cite
Hoshina K, Kaneko M, Hosaka A, et al. Lessons learned from a case of abdominal aortic aneurysm accompanied by unstable coagulopathy. Case Rep Vasc Med. 2012;2012:265860doi: 10.1155/2012/265860.
Hoshina, K., Kaneko, M., Hosaka, A., Okamoto, H., Shigematsu, K., & Miyata, T. (2012). Lessons learned from a case of abdominal aortic aneurysm accompanied by unstable coagulopathy. Case reports in vascular medicine, 2012265860. https://doi.org/10.1155/2012/265860
Hoshina, Katsuyuki, et al. "Lessons learned from a case of abdominal aortic aneurysm accompanied by unstable coagulopathy." Case reports in vascular medicine vol. 2012 (2012): 265860. doi: https://doi.org/10.1155/2012/265860
Hoshina K, Kaneko M, Hosaka A, Okamoto H, Shigematsu K, Miyata T. Lessons learned from a case of abdominal aortic aneurysm accompanied by unstable coagulopathy. Case Rep Vasc Med. 2012;2012:265860. doi: 10.1155/2012/265860. Epub 2012 Aug 09. PMID: 22934232; PMCID: PMC3423788.
Copy Download .nbib Format: NLM
Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation.

Journal of intensive care

Eguchi Y, Gando S, Ishikura H, Saitoh D, Mimuro J, Takahashi H, Kitajima I, Tsuji H, Matsushita T, Tsujita R, Nagao O, Sakata Y.
PMID: 25520842
J Intensive Care. 2014 Apr 30;2(1):30. doi: 10.1186/2052-0492-2-30. eCollection 2014.

BACKGROUND: Thrombomodulin alfa (TM-α, recombinant thrombomodulin) significantly improved disseminated intravascular coagulation (DIC) when compared with heparin therapy in a phase III study. Post-marketing surveillance of TM-α was performed to evaluate the effects and safety in patients with sepsis-induced DIC.METHODS:...

Cite
Eguchi Y, Gando S, Ishikura H, et al. Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation. J Intensive Care. 2014;2(1):30doi: 10.1186/2052-0492-2-30.
Eguchi, Y., Gando, S., Ishikura, H., Saitoh, D., Mimuro, J., Takahashi, H., Kitajima, I., Tsuji, H., Matsushita, T., Tsujita, R., Nagao, O., & Sakata, Y. (2014). Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation. Journal of intensive care, 2(1), 30. https://doi.org/10.1186/2052-0492-2-30
Eguchi, Yutaka, et al. "Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation." Journal of intensive care vol. 2,1 (2014): 30. doi: https://doi.org/10.1186/2052-0492-2-30
Eguchi Y, Gando S, Ishikura H, Saitoh D, Mimuro J, Takahashi H, Kitajima I, Tsuji H, Matsushita T, Tsujita R, Nagao O, Sakata Y. Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation. J Intensive Care. 2014 Apr 30;2(1):30. doi: 10.1186/2052-0492-2-30. eCollection 2014. PMID: 25520842; PMCID: PMC4267702.
Copy Download .nbib Format: NLM
Erratum to: A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.

International journal of hematology

Nomoto H, Takami A, Espinoza JL, Matsuo K, Mizuno S, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Nakao S, Ohtake S, Morishita E.
PMID: 26351240
Int J Hematol. 2015 Oct;102(4):507-8. doi: 10.1007/s12185-015-1867-0.

No abstract available.

Cite
Nomoto H, Takami A, Espinoza JL, et al. Erratum to: A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation. Int J Hematol. 2015;102(4):507-8doi: 10.1007/s12185-015-1867-0.
Nomoto, H., Takami, A., Espinoza, J. L., Matsuo, K., Mizuno, S., Onizuka, M., Kashiwase, K., Morishima, Y., Fukuda, T., Kodera, Y., Doki, N., Miyamura, K., Mori, T., Nakao, S., Ohtake, S., & Morishita, E. (2015). Erratum to: A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation. International journal of hematology, 102(4), 507-8. https://doi.org/10.1007/s12185-015-1867-0
Nomoto, Haruka, et al. "Erratum to: A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation." International journal of hematology vol. 102,4 (2015): 507-8. doi: https://doi.org/10.1007/s12185-015-1867-0
Nomoto H, Takami A, Espinoza JL, Matsuo K, Mizuno S, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Nakao S, Ohtake S, Morishita E. Erratum to: A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation. Int J Hematol. 2015 Oct;102(4):507-8. doi: 10.1007/s12185-015-1867-0. PMID: 26351240.
Copy Download .nbib Format: NLM
Anticoagulant modulation of inflammation in severe sepsis.

World journal of critical care medicine

Allen KS, Sawheny E, Kinasewitz GT.
PMID: 25938026
World J Crit Care Med. 2015 May 04;4(2):105-15. doi: 10.5492/wjccm.v4.i2.105. eCollection 2015 May 04.

Inflammation and coagulation are so tightly linked that the cytokine storm which accompanies the development of sepsis initiates thrombin activation and the development of an intravascular coagulopathy. This review examines the interaction between the inflammatory and coagulation cascades, as...

Cite
Allen KS, Sawheny E, Kinasewitz GT. Anticoagulant modulation of inflammation in severe sepsis. World J Crit Care Med. 2015;4(2):105-15doi: 10.5492/wjccm.v4.i2.105.
Allen, K. S., Sawheny, E., & Kinasewitz, G. T. (2015). Anticoagulant modulation of inflammation in severe sepsis. World journal of critical care medicine, 4(2), 105-15. https://doi.org/10.5492/wjccm.v4.i2.105
Allen, Karen S, et al. "Anticoagulant modulation of inflammation in severe sepsis." World journal of critical care medicine vol. 4,2 (2015): 105-15. doi: https://doi.org/10.5492/wjccm.v4.i2.105
Allen KS, Sawheny E, Kinasewitz GT. Anticoagulant modulation of inflammation in severe sepsis. World J Crit Care Med. 2015 May 04;4(2):105-15. doi: 10.5492/wjccm.v4.i2.105. eCollection 2015 May 04. PMID: 25938026; PMCID: PMC4411562.
Copy Download .nbib Format: NLM
Effect of ulinastatin combined rivaroxaban on deep vein thrombosis in major orthopedic surgery.

Asian Pacific journal of tropical medicine

Yu X, Tian Y, Wang K, Wang YL, Lv GY, Tian GG.
PMID: 25441995
Asian Pac J Trop Med. 2014 Nov;7(11):918-21. doi: 10.1016/S1995-7645(14)60162-0. Epub 2014 Oct 22.

OBJECTIVE: To explore the effect of ulinastatin (UTI) continuous infusion combined Rivaroxaban on the deep vein thrombosis in patients undergoing major orthopedic surgery.METHODS: Forty-five patients undergoing major orthopedic surgery were randomly divided into three groups:ulinastatin continuous infusion (Uc) group,...

Cite
Yu X, Tian Y, Wang K, et al. Effect of ulinastatin combined rivaroxaban on deep vein thrombosis in major orthopedic surgery. Asian Pac J Trop Med. 2014;7(11):918-21doi: 10.1016/S1995-7645(14)60162-0.
Yu, X., Tian, Y., Wang, K., Wang, Y. L., Lv, G. Y., & Tian, G. G. (2014). Effect of ulinastatin combined rivaroxaban on deep vein thrombosis in major orthopedic surgery. Asian Pacific journal of tropical medicine, 7(11), 918-21. https://doi.org/10.1016/S1995-7645(14)60162-0
Yu, Xi, et al. "Effect of ulinastatin combined rivaroxaban on deep vein thrombosis in major orthopedic surgery." Asian Pacific journal of tropical medicine vol. 7,11 (2014): 918-21. doi: https://doi.org/10.1016/S1995-7645(14)60162-0
Yu X, Tian Y, Wang K, Wang YL, Lv GY, Tian GG. Effect of ulinastatin combined rivaroxaban on deep vein thrombosis in major orthopedic surgery. Asian Pac J Trop Med. 2014 Nov;7(11):918-21. doi: 10.1016/S1995-7645(14)60162-0. Epub 2014 Oct 22. PMID: 25441995.
Copy Download .nbib Format: NLM
Myeloproliferative Disease: Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera.

Hematology (Amsterdam, Netherlands)

Musolino C, Alonci A, Bellomo G, Tringali O, Spatari G, Quartarone C, Rizzo V, Calabrò L, Bagnato G, Frisina N.
PMID: 11399581
Hematology. 2000;4(5):397-402.

Vascular complications are the main cause of morbidity in polycythemia vera (PV) and essential thrombocythemia (ET). To investigate plasma concentrations of soluble P-selectin (sP-Sel.), soluble E-selectin (sE-Sel.) and soluble thrombomodulin (sTM) in relation to the presence of thromboembolic events...

Cite
Musolino C, Alonci A, Bellomo G, et al. Myeloproliferative Disease: Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. Hematology. 2000;4(5):397-402
Musolino, C., Alonci, A., Bellomo, G., Tringali, O., Spatari, G., Quartarone, C., Rizzo, V., Calabrò, L., Bagnato, G., & Frisina, N. (2000). Myeloproliferative Disease: Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. Hematology (Amsterdam, Netherlands), 4(5), 397-402.
Musolino, C., et al. "Myeloproliferative Disease: Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera." Hematology (Amsterdam, Netherlands) vol. 4,5 (2000): 397-402.
Musolino C, Alonci A, Bellomo G, Tringali O, Spatari G, Quartarone C, Rizzo V, Calabrò L, Bagnato G, Frisina N. Myeloproliferative Disease: Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. Hematology. 2000;4(5):397-402. PMID: 11399581.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Tomillero A, Moral MA.
PMID: 19557204
Methods Find Exp Clin Pharmacol. 2009 May;31(4):263-98. doi: 10.1358/mf.2009.31.4.1373959.

(-)-Gossypol; Abacavir sulfate/lamivudine, ACAM-1000, ACE-011, Agomelatine, AGS-004, Alemtuzumab, Alvocidib hydrochloride, AMG-317, Amlodipine, Aripiprazole, Atazanavir sulfate, Azacitidine; Becatecarin, Belinostat, Bevacizumab, BMS-387032, BMS-690514, Bortezomib; Casopitant mesylate, Cetuximab, Choline fenofibrate, CK-1827452, Clofarabine, Conivaptan hydrochloride; Dabigatran etexilate, DADMe-Immucillin-H, Darbepoetin alfa, Darunavir, Dasatinib, DC-WT1,...

Cite
Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2009;31(4):263-98doi: 10.1358/mf.2009.31.4.1373959.
Tomillero, A., & Moral, M. A. (2009). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 31(4), 263-98. https://doi.org/10.1358/mf.2009.31.4.1373959
Tomillero, A, and Moral, M A. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 31,4 (2009): 263-98. doi: https://doi.org/10.1358/mf.2009.31.4.1373959
Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2009 May;31(4):263-98. doi: 10.1358/mf.2009.31.4.1373959. PMID: 19557204.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 339 entries